Tau-Directed Immunotherapy: A Promising Strategy for Treating Alzheimer's Disease and Other Tauopathies.
about
The Intersection of NGF/TrkA Signaling and Amyloid Precursor Protein Processing in Alzheimer's Disease NeuropathologyOligomeric tau-targeted immunotherapy in Tg4510 mice.Functional analyses of major cancer-related signaling pathways in Alzheimer's disease etiology.Anti-tau antibody administration increases plasma tau in transgenic mice and patients with tauopathy.MultiTEP platform-based DNA epitope vaccine targeting N-terminus of tau induces strong immune responses and reduces tau pathology in THY-Tau22 mice.Therapeutic strategies for the treatment of tauopathies: Hopes and challenges.Radiopharmaceuticals for Assessment of Altered Metabolism and Biometal Fluxes in Brain Aging and Alzheimer's Disease with Positron Emission Tomography.Internalization of tau antibody and pathological tau protein detected with a flow cytometry multiplexing approachTracking progressive pathological and functional decline in the rTg4510 mouse model of tauopathy."Tau immunotherapy: Hopes and hindrances".Anti-β-sheet conformation monoclonal antibody reduces tau and Aβ oligomer pathology in an Alzheimer's disease model.Prophylactic Active Tau Immunization Leads to Sustained Reduction in Both Tau and Amyloid-β Pathologies in 3xTg Mice.Corticobasal degeneration: key emerging issues.Prospects for strain-specific immunotherapy in Alzheimer's disease and tauopathies.Enhancement of therapeutic potential of a naturally occurring human antibody targeting a phosphorylated Ser422 containing epitope on pathological tau.
P2860
Q33839157-EC7E138E-BBE3-40D7-9FC9-AA15AAA9D458Q33846761-994FB1FA-65DA-4560-A72E-D15D18DAB78AQ38659874-B136A1D3-73A2-4C70-8544-EA6DA959B305Q38829673-F8A1B8B9-16DB-4BFD-B4F6-9C2F822C2B16Q38892738-959E6151-1128-4DB4-A1AF-1DF52DE87447Q38983187-61D93F26-7573-4870-8688-0F74F21627C4Q41535994-B0073A77-3B65-4C0D-B3CE-C249F1DED5FBQ41629521-4D9A4EC5-8995-4624-A361-1A7A986241E1Q41695282-ECA70B72-7EDE-4E05-8728-B93F3DC82360Q47629452-DFE25B5D-120F-4163-88F2-1881503E36FDQ47833979-9DFA83A5-FCA8-4AE0-B562-412DBA46754EQ50045202-FCAEA50D-C975-4EA8-8CBC-2B343ECADF43Q50074075-0B68E835-AD8D-4070-8D42-7E5A2BE871F3Q50532471-6A803636-2E2A-4B8D-BB31-B91B9F9CF94BQ55663766-A195F35E-58A0-4AA8-ABBA-75ACD7D20C85
P2860
Tau-Directed Immunotherapy: A Promising Strategy for Treating Alzheimer's Disease and Other Tauopathies.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Tau-Directed Immunotherapy: A ...... Disease and Other Tauopathies.
@ast
Tau-Directed Immunotherapy: A ...... Disease and Other Tauopathies.
@en
type
label
Tau-Directed Immunotherapy: A ...... Disease and Other Tauopathies.
@ast
Tau-Directed Immunotherapy: A ...... Disease and Other Tauopathies.
@en
prefLabel
Tau-Directed Immunotherapy: A ...... Disease and Other Tauopathies.
@ast
Tau-Directed Immunotherapy: A ...... Disease and Other Tauopathies.
@en
P2093
P2860
P1476
Tau-Directed Immunotherapy: A ...... Disease and Other Tauopathies.
@en
P2093
Aurelie Joly-Amado
Dave Morgan
Marcia N Gordon
Sulana K Schroeder
P2860
P2888
P356
10.1007/S11481-015-9637-6
P577
2015-11-04T00:00:00Z